We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verici Dx Plc | LSE:VRCI | London | Ordinary Share | GB00BM8HZD43 | ORD GBP0.001 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
7.00 | 7.50 | 7.25 | 7.25 | 7.25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | USD | USD -11.41M | USD -0.0470 | -1.91 | 17.58M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
14:17:50 | O | 134,000 | 7.44 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
15/7/2024 | 19:36 | ALNC | EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises |
15/7/2024 | 07:00 | UK RNS | Verici Dx PLC Half-year Report |
11/7/2024 | 14:00 | UK RNS | Verici Dx PLC Notice of Results and Business Update |
01/7/2024 | 14:27 | ALNC | IN BRIEF: Verici Dx hails milestone payment in deal with Thermo Fisher |
01/7/2024 | 07:00 | UK RNS | Verici Dx PLC Significant milestone re Thermo Fisher agreement |
25/6/2024 | 13:27 | UK RNS | Verici Dx PLC Result of AGM |
18/6/2024 | 16:37 | ALNC | EARNINGS AND TRADING: Cordel thrilled by Middle East contract win |
18/6/2024 | 07:00 | UK RNS | Verici Dx PLC Transfer of urine samples to Thermo Fisher |
31/5/2024 | 13:57 | UK RNS | Verici Dx PLC Notice of AGM and posting of Annual Report |
31/5/2024 | 12:46 | ALNC | Verici Dx launches educational website for kidney transplant patients |
Verici Dx (VRCI) Share Charts1 Year Verici Dx Chart |
|
1 Month Verici Dx Chart |
Intraday Verici Dx Chart |
Date | Time | Title | Posts |
---|---|---|---|
26/7/2024 | 18:00 | Verici DX- Break through immuno-diagnostic test | 840 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
2024-07-26 14:17:51 | 7.44 | 134,000 | 9,969.60 | O |
2024-07-26 13:07:16 | 7.00 | 12,500 | 875.00 | O |
2024-07-26 12:32:57 | 7.50 | 14 | 1.05 | O |
2024-07-26 12:31:30 | 7.00 | 40,000 | 2,800.00 | O |
2024-07-26 12:26:58 | 7.01 | 4,983 | 349.31 | O |
Top Posts |
---|
Posted at 26/7/2024 09:20 by Verici Dx Daily Update Verici Dx Plc is listed in the Business Services, Nec sector of the London Stock Exchange with ticker VRCI. The last closing price for Verici Dx was 7.25p.Verici Dx currently has 242,541,467 shares in issue. The market capitalisation of Verici Dx is £21,828,732. Verici Dx has a price to earnings ratio (PE ratio) of -1.91. This morning VRCI shares opened at 7.25p |
Posted at 20/7/2024 16:22 by bri15 They must have been buys Colly otherwise we wouldn't have had yesterday's rise,those two trades were the precursor to our good day yesterday,I just can't get my head around the price and time of trades,as I said, they definitely seemed like sells,but share price said deferently,ATB to yourself. |
Posted at 20/7/2024 15:48 by bri15 Two late trades showed up yesterday from the 18/07,both at 6.81, total shares of 1,350,000,the last trade on 18/07 was a buy at 15.33, trade price was 6.98, going on this price I would think the 2 large delays were sells,yet on Friday morning price rose slightly on first trade,now I not too bright,so can someone explain to me why the share price never dropped on those big trades, unless they somehow were buys,but as I said,the previous trade indicated them as sells,help me please. |
Posted at 18/7/2024 22:44 by rubstick So bri15 I think there are 170million shares and there have been a series of 50000 share trades. That's like 0.29%. That is not a big deal. What is the average share amount traded daily? Has the volume picked up that is perhaps more interesting. |
Posted at 16/7/2024 22:22 by bri15 Well I can't see anything other than a director share purchase moving the SP,we have had very good results RNS yet we still in the doldrums,if my memory is correct at the time of the last results our share price and market cap were considerable higher but results were not as good as yesterday's,ah well, maybe Thermo will treat us to a very early Christmas present,well I can but dream. |
Posted at 16/7/2024 22:18 by videologic Interesting the CEO spoke today of the market in this field(kidney transplant) being worth $10 billion.Imagine if we took a mere 5 per cent. Obviously patience required but this price must be the bottom. Added in the last few days. |
Posted at 04/7/2024 16:30 by bmcollins I share your enthusiasm but I fear that we need to be rather patient, this is AIM after all... |
Posted at 01/7/2024 07:27 by bri15 WHY is the share price here so low? beggars belief the market cap with all this company has going for it, hopefully we will get bought out by Thermo,and if so,at a considerable higher price. |
Posted at 18/6/2024 17:03 by smackeraim That's a huge buy. Hopefully marked the bottom .. come on vrci |
Posted at 22/2/2024 08:06 by bmcollins @smackIndeed thes 3 plus Hargreave Hale are pretty much the AIM focussed VCT's & HH might well have bought anyway but been below a declarable stake. Not to mention that all VCT's tend to hold some AIM shares as a counterweight to their concentration on genuine private start ups, Maven is a good example here, so with this sort of support, not to mention their industry tie ups with larger co's, Unis, this does look well set for success, thus the share price stagnation does surprise me. These VCT's do tend to be long term holders, Amati particularly so as they like to run their winners, some of their stocks were bought over a decade ago and have multiplied in price many times over so whereas on many fund raises there is a significant overhang, I don't see that here. |
Posted at 21/2/2024 11:06 by toffeeman Unicorn paid 6.3p per share.They are uninterested in the share price over the next 5 years. If the company is still independent then they may be paying dividend by then and the VCT pays them to their shareholders tax free. If the company is acquired then Unicorn can pay out a special divi to their shareholders which again is tax free. Treat Unicorn as a passive investor with no impact on the share price. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions